In the early days of the COVID-19 pandemic, scientists began considering prophylactic and therapeutic options for those who became ill from the virus and those who might be at greatest risk of getting infected. This webinar focuses on two promising approaches 1) the use of human convalescent plasma (HCP) treatment; and 2) the development of novel and repurposing of existing antiviral drugs like Remdesivir. Opening remarks from Senator Bob Casey and featuring expert panelists Dr. Arturo Casadevall and Dr. Mark Denison.
- From Remdesivir to Human Convalescent Plasma: Understanding COVID-19 Therapeutic Development ( Download)
- Fighting COVID-19 with Convalescent Plasma, Potent Antibodies, and an Understanding of Immunity ( Download)
- COVID-19: The latest in therapeutics, prevention, and seasonality with Dr. Auwaerter ( Download)
- The COVID-19 Trials: Chasing Potential Treatments | What to Know | WTK ( Download)
- Therpeutic Management of COVID 19 ( Download)
- Trump Is Undergoing Remdesivir Therapy, Here’s What You Need to Know About the Antiviral ( Download)
- Fighting COVID 19 with Convalescent Plasma ( Download)
- Convalescent-plasma therapy for COVID-19 | Novel Treatment ( Download)
- Plasma Treatment for COVID - Does it Work | Convalescent Plasma Therapy ( Download)
- COVID-19 Pandemic Grand Rounds: Management, Treatment, Trials and Off-Label Uses ( Download)
- COVID-19: Convalescent Plasma ( Download)
- The potential of convalescent plasma therapy for COVID-19 patients ( Download)
- Blood Plasma Therapies For COVID-19 ( Download)
- Mayo Clinic Study Finds Using Convalescent Plasma To Treat COVID-19 Appears Safe ( Download)
- Learn from Dr. Ahonkhai about the convalescent plasma treatment for COVID-19 research. ( Download)
